Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate
2004-06-14
2008-10-07
Helms, Larry (Department: 1642)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds expression product or fragment thereof of...
C424S141100, C530S387100, C530S388100, C530S388800, C530S388850, C530S389100, C530S389700
Reexamination Certificate
active
07431926
ABSTRACT:
The invention provides isolated nucleic acid and amino acid sequences of novel human tumor suppressors, antibodies to such tumor suppressors, methods of detecting such nucleic acids and proteins, methods of screening for modulators of tumor suppressors, and methods of diagnosing and treating tumors with such nucleic acids and proteins.
REFERENCES:
patent: 5639656 (1997-06-01), Wright, Jr.
patent: 5840579 (1998-11-01), Boeke et al.
patent: 5849899 (1998-12-01), Hillman et al.
patent: 5986078 (1999-11-01), Garkavtsev et al.
patent: 6403785 (2002-06-01), Nagata et al.
Shimida et al (Cytogenetics and Cell Genetics, 1998, 83:232-235, IDS).
EBSCO, p. 1 only.
R. Ian Freshney, “The Transformed Phenotype”,Culture of Animal Cells a Manual of Basic Technique, 3rded., (Wiley-Liss) ( 1994); pp. 231-241.
Igor Garkavtsev, et al, “Suppression of the novel growth inhibitor p33ING1promotes neoplastic transformation”,Nature Genetics, 14, pp. 415-420; Dec. (1996).
Garkavtsev and Riabowol, “Extension of the Replicative Life Span of Human Diploid Fibroblasts by Inhibition of the p33ING1Candidate Tumor Suppressor”,Molecular and Cellular Biology, 17 (4) pp. 2014-2019 (Apr. 1997).
Igor Garkavtsev, “The candidate tumor suppressor p33ING1cooperates with p53 in cell growth control”Nature, 391, pp. 295-298 (Jan. 15, 1998).
Robert A. Weinberg, “Tumor Suppressor Genes”Science, 254, pp. 1138-1146 (Nov. 22, 1991).
Moshe Oren, “Teaming up to restrain cancer”,Nature, 391:233-234 (1998).
Shimada et al., “Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor”,Cytogenetic, Cell Genet, 83:232-235,(1998).
Garkavtsev et al., “Specific Monoclonal Antibody Raised Against the p33 ING1 Tumor Suppressor”,Hybridoma, 16:(6)537-540 (1997).
Zeremski et al., “Localization of the Candidate Tumor Suppressor Gene INGl to Human Chromosome 13q34”,Somatic Cell and Molecular Genetics, 23:(3) 233-236 (1997).
Helbing et al. “A Novel Candidate Tumor Suppressor, ING1, Is Involved in the Regulation of Apoptosis 1”, 57:7 1255-1258 (1997).
Garkavtsev et al., Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1),Cytogenet and Cell Genet, 76:176-178 (1977).
Harris Curtis C.
Nagashima Makoto
Goddard Laura B
Helms Larry
The United States of America as represented by the Secretary of
Townsend and Townsend / and Crew LLP
LandOfFree
Tumor supressor gene p33ING2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor supressor gene p33ING2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor supressor gene p33ING2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3992306